| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.81e-06 | 188 | 78 | 7 | GO:0005201 | |
| GeneOntologyCellularComponent | extracellular matrix | LRIG2 WNT5B LRIG3 NTN4 INHBE FBN2 VWF MEGF6 WNT5A LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 MUC5AC | 2.02e-08 | 656 | 79 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LRIG2 WNT5B LRIG3 NTN4 INHBE FBN2 VWF MEGF6 WNT5A LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 MUC5AC | 2.10e-08 | 658 | 79 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 3.90e-08 | 10 | 79 | 4 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-5 complex | 2.07e-07 | 4 | 79 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | WNT5B NTN4 INHBE FBN2 VWF MEGF6 WNT5A LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 | 6.82e-07 | 530 | 79 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | Golgi lumen | 5.83e-05 | 109 | 79 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | basement membrane | 9.95e-05 | 122 | 79 | 5 | GO:0005604 | |
| Domain | Growth_fac_rcpt_ | PCSK5 NTN4 FAT1 STAB2 FBN2 CRIM1 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 | 2.38e-15 | 156 | 77 | 14 | IPR009030 |
| Domain | EGF | PCSK5 FAT1 STAB2 FBN2 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 CRB2 | 1.28e-11 | 235 | 77 | 13 | SM00181 |
| Domain | EGF-like_dom | PCSK5 FAT1 STAB2 FBN2 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 CRB2 | 2.65e-11 | 249 | 77 | 13 | IPR000742 |
| Domain | EGF_1 | NTN4 FAT1 STAB2 FBN2 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 CRB2 | 3.57e-11 | 255 | 77 | 13 | PS00022 |
| Domain | EGF-like_CS | NTN4 FAT1 STAB2 FBN2 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 CRB2 | 4.77e-11 | 261 | 77 | 13 | IPR013032 |
| Domain | EGF_Lam | 9.39e-11 | 35 | 77 | 7 | SM00180 | |
| Domain | Laminin_EGF | 1.74e-10 | 38 | 77 | 7 | IPR002049 | |
| Domain | EGF_2 | FAT1 STAB2 FBN2 MEGF6 DLL3 LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 NOTCH4 CRB2 | 8.42e-10 | 265 | 77 | 12 | PS01186 |
| Domain | EGF_LAM_2 | 2.21e-09 | 30 | 77 | 6 | PS50027 | |
| Domain | EGF_LAM_1 | 2.21e-09 | 30 | 77 | 6 | PS01248 | |
| Domain | Laminin_EGF | 5.94e-09 | 35 | 77 | 6 | PF00053 | |
| Domain | LAMININ_IVA | 1.85e-08 | 8 | 77 | 4 | PS51115 | |
| Domain | Laminin_B | 1.85e-08 | 8 | 77 | 4 | PF00052 | |
| Domain | LamB | 1.85e-08 | 8 | 77 | 4 | SM00281 | |
| Domain | Laminin_IV | 1.85e-08 | 8 | 77 | 4 | IPR000034 | |
| Domain | EGF_CA | 3.80e-08 | 122 | 77 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.31e-08 | 124 | 77 | 8 | IPR001881 | |
| Domain | hEGF | 9.53e-08 | 28 | 77 | 5 | PF12661 | |
| Domain | Laminin_N | 4.68e-07 | 16 | 77 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 4.68e-07 | 16 | 77 | 4 | PS51117 | |
| Domain | Laminin_N | 4.68e-07 | 16 | 77 | 4 | PF00055 | |
| Domain | LamNT | 4.68e-07 | 16 | 77 | 4 | SM00136 | |
| Domain | EGF | 8.74e-07 | 126 | 77 | 7 | PF00008 | |
| Domain | VWC_out | 9.87e-07 | 19 | 77 | 4 | SM00215 | |
| Domain | EGF_Ca-bd_CS | 2.96e-06 | 97 | 77 | 6 | IPR018097 | |
| Domain | EGF_CA | 3.33e-06 | 99 | 77 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.53e-06 | 100 | 77 | 6 | PS00010 | |
| Domain | - | 3.72e-06 | 8 | 77 | 3 | 3.90.290.10 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.96e-06 | 106 | 77 | 6 | IPR000152 | |
| Domain | VWC | 5.07e-06 | 28 | 77 | 4 | PF00093 | |
| Domain | EGF_3 | 5.56e-06 | 235 | 77 | 8 | PS50026 | |
| Domain | TB | 5.56e-06 | 9 | 77 | 3 | PS51364 | |
| Domain | TB_dom | 5.56e-06 | 9 | 77 | 3 | IPR017878 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 9.98e-06 | 33 | 77 | 4 | IPR001368 | |
| Domain | VWFC_1 | 1.42e-05 | 36 | 77 | 4 | PS01208 | |
| Domain | VWC | 1.77e-05 | 38 | 77 | 4 | SM00214 | |
| Domain | VWFC_2 | 1.77e-05 | 38 | 77 | 4 | PS50184 | |
| Domain | LAM_G_DOMAIN | 1.77e-05 | 38 | 77 | 4 | PS50025 | |
| Domain | Unchr_dom_Cys-rich | 1.87e-05 | 13 | 77 | 3 | IPR014853 | |
| Domain | C8 | 1.87e-05 | 13 | 77 | 3 | SM00832 | |
| Domain | Laminin_G_2 | 2.18e-05 | 40 | 77 | 4 | PF02210 | |
| Domain | TIL_dom | 2.37e-05 | 14 | 77 | 3 | IPR002919 | |
| Domain | ZF_RING_1 | 2.62e-05 | 291 | 77 | 8 | PS00518 | |
| Domain | VWF_dom | 2.65e-05 | 42 | 77 | 4 | IPR001007 | |
| Domain | EGF_CA | 2.80e-05 | 86 | 77 | 5 | PF07645 | |
| Domain | ZF_RING_2 | 3.10e-05 | 298 | 77 | 8 | PS50089 | |
| Domain | LamG | 3.20e-05 | 44 | 77 | 4 | SM00282 | |
| Domain | VWD | 3.63e-05 | 16 | 77 | 3 | SM00216 | |
| Domain | VWF_type-D | 3.63e-05 | 16 | 77 | 3 | IPR001846 | |
| Domain | VWFD | 3.63e-05 | 16 | 77 | 3 | PS51233 | |
| Domain | VWD | 3.63e-05 | 16 | 77 | 3 | PF00094 | |
| Domain | RING | 3.65e-05 | 305 | 77 | 8 | SM00184 | |
| Domain | Znf_RING | 5.84e-05 | 326 | 77 | 8 | IPR001841 | |
| Domain | Laminin_G | 9.57e-05 | 58 | 77 | 4 | IPR001791 | |
| Domain | EGF_extracell | 1.09e-04 | 60 | 77 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.09e-04 | 60 | 77 | 4 | PF07974 | |
| Domain | Znf_RING/FYVE/PHD | 1.11e-04 | 459 | 77 | 9 | IPR013083 | |
| Domain | Laminin_aI | 1.66e-04 | 5 | 77 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.66e-04 | 5 | 77 | 2 | PF06008 | |
| Domain | Laminin_II | 1.66e-04 | 5 | 77 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.66e-04 | 5 | 77 | 2 | IPR010307 | |
| Domain | TNFR_NGFR_1 | 2.28e-04 | 29 | 77 | 3 | PS00652 | |
| Domain | TNFR_NGFR_2 | 2.28e-04 | 29 | 77 | 3 | PS50050 | |
| Domain | WxxW_domain | 2.49e-04 | 6 | 77 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.49e-04 | 6 | 77 | 2 | PF13330 | |
| Domain | ConA-like_dom | 2.88e-04 | 219 | 77 | 6 | IPR013320 | |
| Domain | TB | 3.48e-04 | 7 | 77 | 2 | PF00683 | |
| Domain | Hirudin/antistatin | 3.48e-04 | 7 | 77 | 2 | IPR011061 | |
| Domain | - | 5.17e-04 | 449 | 77 | 8 | 3.30.40.10 | |
| Domain | Galactose-bd-like | 6.15e-04 | 94 | 77 | 4 | IPR008979 | |
| Domain | - | 6.40e-04 | 95 | 77 | 4 | 2.60.120.200 | |
| Domain | TIL | 1.08e-03 | 12 | 77 | 2 | PF01826 | |
| Domain | C8 | 1.08e-03 | 12 | 77 | 2 | PF08742 | |
| Domain | Glyco_hormone_CN | 1.70e-03 | 15 | 77 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.70e-03 | 15 | 77 | 2 | PF00007 | |
| Domain | zf-C3HC4 | 2.28e-03 | 223 | 77 | 5 | PF00097 | |
| Domain | CTCK_1 | 2.46e-03 | 18 | 77 | 2 | PS01185 | |
| Domain | KAZAL_1 | 2.46e-03 | 18 | 77 | 2 | PS00282 | |
| Domain | Wnt | 2.74e-03 | 19 | 77 | 2 | IPR005817 | |
| Domain | Wnt_CS | 2.74e-03 | 19 | 77 | 2 | IPR018161 | |
| Domain | wnt | 2.74e-03 | 19 | 77 | 2 | PF00110 | |
| Domain | NTR | 2.74e-03 | 19 | 77 | 2 | PF01759 | |
| Domain | WNT1 | 2.74e-03 | 19 | 77 | 2 | SM00097 | |
| Domain | WNT1 | 2.74e-03 | 19 | 77 | 2 | PS00246 | |
| Domain | Netrin_module_non-TIMP | 2.74e-03 | 19 | 77 | 2 | IPR018933 | |
| Domain | TNFR_c6 | 3.67e-03 | 22 | 77 | 2 | PF00020 | |
| Domain | CT | 3.67e-03 | 22 | 77 | 2 | SM00041 | |
| Domain | NTR | 4.01e-03 | 23 | 77 | 2 | PS50189 | |
| Domain | Netrin_domain | 4.01e-03 | 23 | 77 | 2 | IPR001134 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.37e-06 | 59 | 61 | 5 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.99e-06 | 30 | 61 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.99e-06 | 30 | 61 | 4 | M27216 | |
| Pathway | WP_CANCER_PATHWAYS | WNT5B FZD8 PIM2 WNT5A DLL3 LAMA3 LAMA5 BIRC3 LAMC2 LAMC3 NOTCH4 | 9.57e-06 | 507 | 61 | 11 | M48302 |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.24e-05 | 11 | 61 | 3 | M158 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.85e-05 | 41 | 61 | 4 | M27778 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.05e-05 | 84 | 61 | 5 | M3228 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.05e-05 | 84 | 61 | 5 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.24e-05 | 300 | 61 | 8 | M610 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.52e-05 | 46 | 61 | 4 | M239 | |
| Pathway | REACTOME_REGULATION_OF_TNFR1_SIGNALING | 4.92e-05 | 47 | 61 | 4 | MM15179 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 5.80e-05 | 96 | 61 | 5 | M39834 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 7.44e-05 | 325 | 61 | 8 | M12868 | |
| Pathway | REACTOME_TNF_SIGNALING | 9.85e-05 | 56 | 61 | 4 | MM15453 | |
| Pathway | REACTOME_TNF_SIGNALING | 1.06e-04 | 57 | 61 | 4 | M27713 | |
| Pathway | REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING | 1.28e-04 | 23 | 61 | 3 | MM15177 | |
| Pathway | WP_FOCAL_ADHESION | 1.52e-04 | 187 | 61 | 6 | MM15913 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.54e-04 | 118 | 61 | 5 | M39852 | |
| Pathway | REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING | 1.66e-04 | 25 | 61 | 3 | M27435 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 1.66e-04 | 25 | 61 | 3 | MM15931 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 1.87e-04 | 26 | 61 | 3 | M39784 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY | 1.87e-04 | 26 | 61 | 3 | MM15892 | |
| Pathway | WP_SPHINGOLIPID_METABOLISM_OVERVIEW | 2.09e-04 | 27 | 61 | 3 | M39863 | |
| Pathway | WP_FOCAL_ADHESION | 2.14e-04 | 199 | 61 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 2.14e-04 | 199 | 61 | 6 | M7253 | |
| Pathway | WP_AXON_GUIDANCE | 2.62e-04 | 72 | 61 | 4 | M48335 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.88e-04 | 30 | 61 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.88e-04 | 30 | 61 | 3 | MM15812 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 3.65e-04 | 142 | 61 | 5 | MM15431 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.74e-04 | 79 | 61 | 4 | M27643 | |
| Pathway | REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY | 3.83e-04 | 33 | 61 | 3 | M27438 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 3.83e-04 | 33 | 61 | 3 | M39503 | |
| Pathway | REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY | 3.83e-04 | 33 | 61 | 3 | MM15180 | |
| Pathway | KEGG_PRIMARY_IMMUNODEFICIENCY | 4.57e-04 | 35 | 61 | 3 | M4085 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 4.97e-04 | 36 | 61 | 3 | M39699 | |
| Pathway | REACTOME_DEATH_RECEPTOR_SIGNALING | 5.30e-04 | 154 | 61 | 5 | M27697 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 5.30e-04 | 154 | 61 | 5 | M39739 | |
| Pathway | KEGG_SPHINGOLIPID_METABOLISM | 6.31e-04 | 39 | 61 | 3 | M15955 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 6.49e-04 | 161 | 61 | 5 | M39770 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 6.50e-04 | 9 | 61 | 2 | M47866 | |
| Pathway | BIOCARTA_SODD_PATHWAY | 8.11e-04 | 10 | 61 | 2 | M2699 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 9.00e-04 | 44 | 61 | 3 | MM15878 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 9.61e-04 | 45 | 61 | 3 | M47412 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 9.88e-04 | 11 | 61 | 2 | M27372 | |
| Pathway | PID_TNF_PATHWAY | 1.03e-03 | 46 | 61 | 3 | M128 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.03e-03 | 46 | 61 | 3 | M47409 | |
| Pathway | REACTOME_GLYCOPROTEIN_HORMONES | 1.39e-03 | 13 | 61 | 2 | MM14830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.39e-03 | 13 | 61 | 2 | M47423 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS | 1.62e-03 | 14 | 61 | 2 | M756 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 1.72e-03 | 55 | 61 | 3 | M17807 | |
| Pathway | REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS | 1.87e-03 | 15 | 61 | 2 | MM14832 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.87e-03 | 15 | 61 | 2 | M27161 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 2.13e-03 | 16 | 61 | 2 | M47424 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 2.13e-03 | 16 | 61 | 2 | M47823 | |
| Pathway | WP_WNT_SIGNALING | 2.32e-03 | 61 | 61 | 3 | MM15893 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 2.77e-03 | 439 | 61 | 7 | M42563 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.91e-03 | 66 | 61 | 3 | MM15925 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.91e-03 | 66 | 61 | 3 | M18 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 3.00e-03 | 19 | 61 | 2 | M47836 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.14e-03 | 140 | 61 | 4 | M587 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.16e-03 | 68 | 61 | 3 | M27303 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 8.90e-09 | 11 | 81 | 4 | 21524702 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.65e-08 | 15 | 81 | 4 | 15895400 | |
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 29378181 | ||
| Pubmed | 4.86e-08 | 4 | 81 | 3 | 10651091 | ||
| Pubmed | 4.86e-08 | 16 | 81 | 4 | 17601529 | ||
| Pubmed | 8.15e-08 | 18 | 81 | 4 | 11311202 | ||
| Pubmed | 1.29e-07 | 20 | 81 | 4 | 22911573 | ||
| Pubmed | 3.92e-07 | 26 | 81 | 4 | 24742657 | ||
| Pubmed | 4.23e-07 | 7 | 81 | 3 | 7921537 | ||
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 20093360 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 6.76e-07 | 8 | 81 | 3 | 9489770 | |
| Pubmed | 6.76e-07 | 8 | 81 | 3 | 8872465 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 6.76e-07 | 8 | 81 | 3 | 23529140 | |
| Pubmed | 1.01e-06 | 9 | 81 | 3 | 12122015 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.19e-06 | 79 | 81 | 5 | 18757743 | |
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 11784026 | ||
| Pubmed | 1.44e-06 | 10 | 81 | 3 | 9034910 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 1.98e-06 | 11 | 81 | 3 | 8707838 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.98e-06 | 11 | 81 | 3 | 23472759 | |
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 26794322 | ||
| Pubmed | 2.64e-06 | 12 | 81 | 3 | 9396756 | ||
| Pubmed | 3.54e-06 | 175 | 81 | 6 | 28071719 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LRIG2 FAT1 FBN2 FSTL3 CRIM1 SPTLC2 WNT5A LAMA5 LAMC3 GRN SMPD1 LTBP2 TAP1 | 3.95e-06 | 1201 | 81 | 13 | 35696571 |
| Pubmed | 4.35e-06 | 14 | 81 | 3 | 36347239 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 15203213 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24703938 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 17393120 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12165812 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 11810295 | ||
| Pubmed | Cross-talk between CD38 and TTP Is Essential for Resolution of Inflammation during Microbial Sepsis. | 5.36e-06 | 2 | 81 | 2 | 31995750 | |
| Pubmed | Prognostic significance of LRIG2 and LRIG3 proteins in urothelial bladder carcinoma. | 5.36e-06 | 2 | 81 | 2 | 34839782 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 19839997 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 9010770 | ||
| Pubmed | PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. | 5.36e-06 | 2 | 81 | 2 | 29570932 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24383743 | ||
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 12382139 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 5.36e-06 | 2 | 81 | 2 | 17000025 | |
| Pubmed | Mesenchymal WNT-5A/5B Signaling Represses Lung Alveolar Epithelial Progenitors. | 5.36e-06 | 2 | 81 | 2 | 31557955 | |
| Pubmed | Reduced immunoglobulin class switch recombination in the absence of Artemis. | 5.36e-06 | 2 | 81 | 2 | 19692705 | |
| Pubmed | Tristetraprolin controls the stability of cIAP2 mRNA through binding to the 3'UTR of cIAP2 mRNA. | 5.36e-06 | 2 | 81 | 2 | 20691152 | |
| Pubmed | 5.36e-06 | 2 | 81 | 2 | 24139281 | ||
| Pubmed | Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. | 5.36e-06 | 2 | 81 | 2 | 19582886 | |
| Pubmed | 5.43e-06 | 15 | 81 | 3 | 19703589 | ||
| Pubmed | 5.43e-06 | 15 | 81 | 3 | 9264260 | ||
| Pubmed | WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. | 5.79e-06 | 50 | 81 | 4 | 18351662 | |
| Pubmed | Cooperative and independent functions of FGF and Wnt signaling during early inner ear development. | 8.08e-06 | 17 | 81 | 3 | 26443994 | |
| Pubmed | 8.61e-06 | 118 | 81 | 5 | 21078624 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 FAT1 KMT2D MEGF6 SHISA5 MEX3D OSBPL5 NLRC5 LAMA5 LAMC3 GRIN2D SPPL2B | 9.37e-06 | 1105 | 81 | 12 | 35748872 |
| Pubmed | 1.57e-05 | 21 | 81 | 3 | 27856617 | ||
| Pubmed | Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. | 1.57e-05 | 21 | 81 | 3 | 19129494 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 10706852 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26976640 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21393509 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 15373767 | ||
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 1.60e-05 | 3 | 81 | 2 | 16165127 | |
| Pubmed | LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers. | 1.60e-05 | 3 | 81 | 2 | 27628597 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 8113417 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 24399733 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 27375110 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 1.60e-05 | 3 | 81 | 2 | 16537560 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18697739 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 29740434 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 8012114 | ||
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 1.60e-05 | 3 | 81 | 2 | 15316072 | |
| Pubmed | Role of Noncanonical Wnt Signaling Pathway in Human Aortic Valve Calcification. | 1.60e-05 | 3 | 81 | 2 | 27932350 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 1.60e-05 | 3 | 81 | 2 | 17482449 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 18037903 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 1.60e-05 | 3 | 81 | 2 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 1.60e-05 | 3 | 81 | 2 | 18603785 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21700711 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 33179081 | ||
| Pubmed | The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity. | 1.60e-05 | 3 | 81 | 2 | 30124466 | |
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 1.60e-05 | 3 | 81 | 2 | 15149852 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 31123786 | ||
| Pubmed | A dermal HOX transcriptional program regulates site-specific epidermal fate. | 1.60e-05 | 3 | 81 | 2 | 18245445 | |
| Pubmed | LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes. | 1.60e-05 | 3 | 81 | 2 | 33469151 | |
| Pubmed | Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis. | 1.60e-05 | 3 | 81 | 2 | 38461416 | |
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 1.60e-05 | 3 | 81 | 2 | 15854126 | |
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 1.60e-05 | 3 | 81 | 2 | 16179086 | |
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 17137774 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 21980498 | ||
| Pubmed | 1.60e-05 | 3 | 81 | 2 | 26394601 | ||
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 1.60e-05 | 3 | 81 | 2 | 10853832 | |
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 2.70e-05 | 25 | 81 | 3 | 12812787 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 3.04e-05 | 26 | 81 | 3 | 34189436 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 19752234 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 37722486 | ||
| Pubmed | Binding of netrin-4 to laminin short arms regulates basement membrane assembly. | 3.20e-05 | 4 | 81 | 2 | 17588941 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 10801807 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 8081888 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 22101459 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 16115200 | ||
| Pubmed | Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. | 3.20e-05 | 4 | 81 | 2 | 22863009 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 22201128 | ||
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 3.20e-05 | 4 | 81 | 2 | 10806203 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 22673183 | ||
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 19577541 | ||
| Pubmed | Post-transcriptional regulation of satellite cell quiescence by TTP-mediated mRNA decay. | 3.20e-05 | 4 | 81 | 2 | 25815583 | |
| Pubmed | 3.20e-05 | 4 | 81 | 2 | 11588035 | ||
| Interaction | IGFL3 interactions | 4.17e-07 | 75 | 77 | 6 | int:IGFL3 | |
| Interaction | MFAP5 interactions | 1.61e-06 | 52 | 77 | 5 | int:MFAP5 | |
| Interaction | FBXO2 interactions | 3.62e-06 | 411 | 77 | 10 | int:FBXO2 | |
| Interaction | LLCFC1 interactions | 6.92e-06 | 121 | 77 | 6 | int:LLCFC1 | |
| Interaction | SPSB4 interactions | 7.97e-06 | 124 | 77 | 6 | int:SPSB4 | |
| Interaction | DEFA1 interactions | 4.05e-05 | 100 | 77 | 5 | int:DEFA1 | |
| Interaction | HOXA1 interactions | 6.38e-05 | 356 | 77 | 8 | int:HOXA1 | |
| Interaction | VWCE interactions | 1.05e-04 | 64 | 77 | 4 | int:VWCE | |
| Interaction | CACNA1A interactions | 1.09e-04 | 123 | 77 | 5 | int:CACNA1A | |
| Cytoband | 12p13.3 | 1.33e-03 | 30 | 82 | 2 | 12p13.3 | |
| Cytoband | 11q14.3 | 1.51e-03 | 32 | 82 | 2 | 11q14.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.08e-03 | 797 | 82 | 6 | chr19p13 | |
| Cytoband | 17q21.32 | 3.51e-03 | 49 | 82 | 2 | 17q21.32 | |
| GeneFamily | Laminin subunits | 2.96e-08 | 12 | 52 | 4 | 626 | |
| GeneFamily | Ring finger proteins | 1.30e-05 | 275 | 52 | 7 | 58 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 7.78e-05 | 29 | 52 | 3 | 782 | |
| GeneFamily | Wnt family|Endogenous ligands | 1.34e-03 | 19 | 52 | 2 | 360 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 2.58e-03 | 95 | 52 | 3 | 59 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.79e-11 | 191 | 81 | 11 | MM17059 | |
| Coexpression | NABA_MATRISOME | WNT5B PCSK5 NTN4 INHBE CILP2 FBN2 VWF FSTL3 CRIM1 MEGF6 SEMA5B WFIKKN1 WNT5A KCP LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 MUC5AC | 2.11e-11 | 1008 | 81 | 20 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.37e-11 | 196 | 81 | 11 | M3008 | |
| Coexpression | NABA_MATRISOME | WNT5B PCSK5 NTN4 INHBE CILP2 FBN2 VWF FSTL3 CRIM1 MEGF6 SEMA5B WFIKKN1 WNT5A KCP LAMA3 LAMA5 LAMC2 LAMC3 LTBP2 MUC5AC | 2.89e-11 | 1026 | 81 | 20 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 7.25e-10 | 270 | 81 | 11 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 8.79e-10 | 275 | 81 | 11 | M5884 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.50e-07 | 40 | 81 | 5 | M5887 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 2.83e-06 | 199 | 81 | 7 | M9420 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP | 1.26e-05 | 15 | 81 | 3 | M48289 | |
| Coexpression | LEF1_UP.V1_UP | 3.11e-05 | 194 | 81 | 6 | M2905 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 3.12e-05 | 20 | 81 | 3 | MM17053 | |
| Coexpression | GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN | 3.69e-05 | 200 | 81 | 6 | M7642 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.69e-05 | 200 | 81 | 6 | M5930 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_DN | 3.69e-05 | 200 | 81 | 6 | M6829 | |
| Coexpression | GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP | 3.69e-05 | 200 | 81 | 6 | M8690 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 4.20e-05 | 124 | 81 | 5 | M45686 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.82e-05 | 23 | 81 | 3 | M48001 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | PCSK5 TRIM64B GTF3A IRF2BP1 OSBPL5 SMPD1 TRIM64 GRIN2D MUC5AC TRIM64C NOTCH4 | 7.44e-05 | 871 | 81 | 11 | MM1005 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.16e-04 | 355 | 81 | 7 | M45758 | |
| Coexpression | COLINA_TARGETS_OF_4EBP1_AND_4EBP2 | 1.24e-04 | 359 | 81 | 7 | M1919 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 1.53e-04 | 163 | 81 | 5 | M12112 | |
| Coexpression | RODWELL_AGING_KIDNEY_UP | 1.60e-04 | 501 | 81 | 8 | M5389 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | CERK FSTL3 CRIM1 MEGF6 SPTLC2 LAMA3 LAMA5 LAMC2 LTBP2 TAP1 CRB2 | 1.67e-04 | 955 | 81 | 11 | M45680 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.52e-04 | 681 | 81 | 9 | M5314 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_UP | 2.52e-04 | 284 | 81 | 6 | M19993 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP | 2.93e-04 | 292 | 81 | 6 | M41140 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 2.99e-04 | 42 | 81 | 3 | M5895 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 3.18e-04 | 703 | 81 | 9 | MM1055 | |
| Coexpression | GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP | 3.27e-04 | 192 | 81 | 5 | M4677 | |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_UP | 3.27e-04 | 192 | 81 | 5 | M6732 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 3.35e-04 | 193 | 81 | 5 | M39321 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP | 3.35e-04 | 193 | 81 | 5 | M3487 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_DN | 3.76e-04 | 198 | 81 | 5 | M9407 | |
| Coexpression | CHENG_IMPRINTED_BY_ESTRADIOL | 3.81e-04 | 110 | 81 | 4 | M19202 | |
| Coexpression | GSE4142_NAIVE_VS_GC_BCELL_UP | 3.85e-04 | 199 | 81 | 5 | M6375 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 3.85e-04 | 199 | 81 | 5 | M6450 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 3.85e-04 | 199 | 81 | 5 | M9595 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN | 3.85e-04 | 199 | 81 | 5 | M3440 | |
| Coexpression | GSE17721_CTRL_VS_LPS_12H_BMDC_DN | 3.85e-04 | 199 | 81 | 5 | M3702 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP | 3.94e-04 | 200 | 81 | 5 | M8026 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 3.94e-04 | 200 | 81 | 5 | M9598 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 3.94e-04 | 200 | 81 | 5 | M5913 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 3.94e-04 | 200 | 81 | 5 | M9576 | |
| Coexpression | GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN | 3.94e-04 | 200 | 81 | 5 | M3411 | |
| Coexpression | GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP | 3.94e-04 | 200 | 81 | 5 | M9023 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN | 3.94e-04 | 200 | 81 | 5 | M4459 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 4.31e-04 | 204 | 81 | 5 | M34006 | |
| Coexpression | CHANDRAN_METASTASIS_DN | 4.45e-04 | 316 | 81 | 6 | M11615 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 4.53e-04 | 738 | 81 | 9 | MM17058 | |
| Coexpression | BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP | 4.61e-04 | 207 | 81 | 5 | M14539 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-08 | 154 | 82 | 7 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-08 | 188 | 82 | 7 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.80e-08 | 188 | 82 | 7 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 166 | 82 | 6 | 8e2faca6a2e76a625de04d6098aa6f98911945c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-07 | 173 | 82 | 6 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 9.00e-07 | 176 | 82 | 6 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 181 | 82 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 181 | 82 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.32e-06 | 188 | 82 | 6 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-06 | 189 | 82 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-06 | 189 | 82 | 6 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.54e-06 | 193 | 82 | 6 | 5c5543e7c83ecea44d23521246592c0301044173 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.54e-06 | 193 | 82 | 6 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.59e-06 | 194 | 82 | 6 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | 0b0615553b9a1b60d666d074ce4260919e2d5642 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 195 | 82 | 6 | bb30ac112f8c42d113fa83a9b662e40c0685bb1e | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.73e-06 | 197 | 82 | 6 | 749e0e332644543cbdf2ee38c2b301ce0a019a7f | |
| ToppCell | mild-Plasmablast|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.79e-06 | 198 | 82 | 6 | b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Endothelial|Endothelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.89e-06 | 200 | 82 | 6 | 2ae62c428728c1d9d4471d4be24bd6ab074fa22c | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.25e-06 | 145 | 82 | 5 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.25e-06 | 145 | 82 | 5 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 153 | 82 | 5 | 3724dd498b982be693ddff9cea7671863acf3ff8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.41e-06 | 153 | 82 | 5 | d810fc5aff28449ce79b4148558b260878a2c696 | |
| ToppCell | Adult-Immune-B_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.00e-05 | 155 | 82 | 5 | 5857aebd43b901fc9f8c46f2d628582969db9e6a | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 160 | 82 | 5 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | ICU-NoSEP-Lymphocyte-B-Plasmablast|ICU-NoSEP / Disease, Lineage and Cell Type | 1.20e-05 | 161 | 82 | 5 | 8ca34d800551cb0f796293e6bfdcbf58509cc668 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.28e-05 | 163 | 82 | 5 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 170 | 82 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.61e-05 | 171 | 82 | 5 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | COVID-19-kidney-Plasma|kidney / Disease (COVID-19 only), tissue and cell type | 1.61e-05 | 171 | 82 | 5 | a59a054b8e119215f24dc5c80ad5a8094b3500f9 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 83 | 82 | 4 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 83 | 82 | 4 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 83 | 82 | 4 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.69e-05 | 83 | 82 | 4 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-05 | 173 | 82 | 5 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | AT1_cells-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-05 | 173 | 82 | 5 | b29816427428c7053017477f59b828bf1357f3b2 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-05 | 174 | 82 | 5 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | BAL-Control-cDC_11|Control / Compartment, Disease Groups and Clusters | 1.80e-05 | 175 | 82 | 5 | daf014e15a354956e9149c83fd89d0af0d07eb00 | |
| ToppCell | Healthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.85e-05 | 176 | 82 | 5 | 7765a5b04ac117d525201f8eb08e1754e55942ff | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 176 | 82 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 176 | 82 | 5 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 179 | 82 | 5 | dfd5b25f2a6a5a8bf4714f1516cb0997de72b06f | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-05 | 179 | 82 | 5 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 179 | 82 | 5 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-05 | 180 | 82 | 5 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 82 | 5 | 6cdee2f56bc633b387b4dbbd78c624edbd712c24 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.12e-05 | 181 | 82 | 5 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 181 | 82 | 5 | b75b8b025257bccfe661fd0f92ab284b2a9c12ee | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-05 | 183 | 82 | 5 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.23e-05 | 183 | 82 | 5 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 2.23e-05 | 183 | 82 | 5 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.23e-05 | 183 | 82 | 5 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-05 | 184 | 82 | 5 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.35e-05 | 185 | 82 | 5 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 185 | 82 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-05 | 185 | 82 | 5 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | metastatic_Brain-B_lymphocytes|metastatic_Brain / Location, Cell class and cell subclass | 2.35e-05 | 185 | 82 | 5 | 153b82dc5ace03f84dc82d724d56bdc93aa020df | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-05 | 185 | 82 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.41e-05 | 186 | 82 | 5 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-05 | 187 | 82 | 5 | d2296f2722a24b289fed7e6cfdc2105608437c3e | |
| ToppCell | metastatic_Brain-T/NK_cells-Treg|metastatic_Brain / Location, Cell class and cell subclass | 2.48e-05 | 187 | 82 | 5 | 1b88e1399809c50a0156096d9c82b1d9e58bb720 | |
| ToppCell | Bac-SEP-Lymphocyte-B|Bac-SEP / Disease, Lineage and Cell Type | 2.48e-05 | 187 | 82 | 5 | 027aa7b5be402fc82ae13c346dfb4c0c751a07e9 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.48e-05 | 187 | 82 | 5 | 06a0f0a27569af89f86ed8cddb608454a3d40cc5 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.54e-05 | 188 | 82 | 5 | 50b27fc12347ca16bd62333baf345c83cb422a8f | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 188 | 82 | 5 | 8e1220066008aef171692c6afffcf31833a3fae8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 188 | 82 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 188 | 82 | 5 | 31d7e62cce010eed1c2db6d6eb55806d27b26151 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 2.60e-05 | 189 | 82 | 5 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 2.60e-05 | 189 | 82 | 5 | dceb011216deb4ffd830144a53c635c05dff5ec5 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.67e-05 | 190 | 82 | 5 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.67e-05 | 190 | 82 | 5 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.67e-05 | 190 | 82 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 190 | 82 | 5 | d87b9e9ca863270a9c7f61674271a6440c97d1f4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.67e-05 | 190 | 82 | 5 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 190 | 82 | 5 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.67e-05 | 190 | 82 | 5 | 84eb7761f537d270673909a71d4f122e826769d5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.74e-05 | 191 | 82 | 5 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.74e-05 | 191 | 82 | 5 | 84452125d1b5b76974e3f9126f611eff16d45c25 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 191 | 82 | 5 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 191 | 82 | 5 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-05 | 192 | 82 | 5 | 285a9d332a1e07b94f222d4b518dd56928b9e075 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.81e-05 | 192 | 82 | 5 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 82 | 5 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-05 | 192 | 82 | 5 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 193 | 82 | 5 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 193 | 82 | 5 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.88e-05 | 193 | 82 | 5 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-05 | 193 | 82 | 5 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 193 | 82 | 5 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 193 | 82 | 5 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.88e-05 | 193 | 82 | 5 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-05 | 194 | 82 | 5 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.95e-05 | 194 | 82 | 5 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.95e-05 | 194 | 82 | 5 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| Computational | Adhesion molecules. | 3.59e-06 | 141 | 50 | 7 | MODULE_122 | |
| Computational | Placenta genes. | 4.34e-05 | 463 | 50 | 10 | MODULE_38 | |
| Computational | Immune (humoral) and inflammatory response. | VWF PIM2 CRIM1 LAMA3 TNFRSF13B BIRC3 GRN TNFRSF10D TNFRSF1B TAP1 | 1.72e-04 | 546 | 50 | 10 | MODULE_84 |
| Computational | Secreted signaling molecules. | 6.14e-04 | 149 | 50 | 5 | MODULE_92 | |
| Computational | Lung genes. | 7.99e-04 | 434 | 50 | 8 | MODULE_5 | |
| Drug | AC1L1G72 | 4.13e-08 | 11 | 78 | 4 | CID000003553 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.40e-06 | 162 | 78 | 7 | 1655_UP | |
| Drug | Mifepristone | LHB NTN4 KMT2D VWF FSTL3 WNT5A LAMA3 LAMA5 LAMC2 ZFP36 NOTCH4 | 2.81e-06 | 553 | 78 | 11 | ctd:D015735 |
| Drug | AC1L1B58 | 2.84e-06 | 29 | 78 | 4 | CID000001288 | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 5.48e-06 | 199 | 78 | 7 | 5995_UP | |
| Drug | BM165 | 6.26e-06 | 11 | 78 | 3 | CID003352881 | |
| Drug | YIGSR | 7.66e-06 | 79 | 78 | 5 | CID000123977 | |
| Drug | Calcort | 8.61e-06 | 38 | 78 | 4 | CID000026709 | |
| Drug | 1,2-dimethylhydrazine | 1.16e-05 | 86 | 78 | 5 | CID000001322 | |
| Drug | Rgd Peptide | 1.80e-05 | 239 | 78 | 7 | CID000104802 | |
| Drug | ciclesonide | 2.21e-05 | 48 | 78 | 4 | CID000444033 | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 3.07e-05 | 175 | 78 | 6 | 3295_UP | |
| Drug | Rgds Peptide | 3.21e-05 | 106 | 78 | 5 | CID000107775 | |
| Drug | AC1O0B8G | 3.25e-05 | 262 | 78 | 7 | CID000091605 | |
| Drug | kalinin | 3.81e-05 | 55 | 78 | 4 | CID000032518 | |
| Drug | B-Ms | 4.55e-05 | 114 | 78 | 5 | CID000445091 | |
| Drug | ALT-711 | 4.92e-05 | 21 | 78 | 3 | CID000216304 | |
| Drug | CC270 | 5.03e-05 | 59 | 78 | 4 | CID006918852 | |
| Drug | LG 5 | 5.37e-05 | 60 | 78 | 4 | CID011840957 | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 5.79e-05 | 196 | 78 | 6 | 2862_UP | |
| Drug | Practolol [6673-35-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 5664_UP | |
| Drug | Sikvav | 7.43e-05 | 24 | 78 | 3 | CID005487517 | |
| Drug | L-cycloserine | 7.82e-05 | 66 | 78 | 4 | CID000000401 | |
| Drug | pyrachlostrobin | WNT5B NTN4 SSPN FAT1 LAMA5 GRN LTBP2 TNFRSF1B TAP1 ZFP36 CRB2 | 9.66e-05 | 811 | 78 | 11 | ctd:C513428 |
| Disease | lung small cell carcinoma (is_implicated_in) | 8.37e-07 | 28 | 77 | 4 | DOID:5409 (is_implicated_in) | |
| Disease | ankylosing spondylitis (is_implicated_in) | 1.61e-05 | 19 | 77 | 3 | DOID:7147 (is_implicated_in) | |
| Disease | Junctional epidermolysis bullosa | 2.01e-05 | 3 | 77 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 2.01e-05 | 3 | 77 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 2.01e-05 | 3 | 77 | 2 | 226700 | |
| Disease | Epidermolysis Bullosa Progressiva | 4.02e-05 | 4 | 77 | 2 | C0079297 | |
| Disease | Herlitz Disease | 4.02e-05 | 4 | 77 | 2 | C0079683 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 6.69e-05 | 5 | 77 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 6.69e-05 | 5 | 77 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 6.69e-05 | 5 | 77 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 1.00e-04 | 6 | 77 | 2 | C0079301 | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 1.40e-04 | 7 | 77 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | psoriasis (implicated_via_orthology) | 1.40e-04 | 7 | 77 | 2 | DOID:8893 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | 1.84e-04 | 774 | 77 | 9 | C0023893 | |
| Disease | response to lithium ion | 4.29e-04 | 56 | 77 | 3 | GO_0010226 | |
| Disease | dementia (is_implicated_in) | 4.36e-04 | 12 | 77 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | colon carcinoma (is_marker_for) | 5.15e-04 | 13 | 77 | 2 | DOID:1520 (is_marker_for) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 9.69e-04 | 74 | 77 | 3 | DOID:3748 (is_marker_for) | |
| Disease | factor VIII measurement, Ischemic stroke | 1.12e-03 | 19 | 77 | 2 | EFO_0004630, HP_0002140 | |
| Disease | bipolar disorder (is_marker_for) | 1.12e-03 | 19 | 77 | 2 | DOID:3312 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.45e-03 | 85 | 77 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | orofacial cleft, sex interaction measurement | 1.50e-03 | 86 | 77 | 3 | EFO_0008343, MONDO_0000358 | |
| Disease | Sezary Syndrome | 2.26e-03 | 27 | 77 | 2 | C0036920 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 2.26e-03 | 27 | 77 | 2 | EFO_0004629, EFO_0004630 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RECLPLTCSSRCRLP | 581 | A6NF34 | |
| LTCSSRCRLPPARCL | 586 | A6NF34 | |
| PDCADPLCCRRGSGL | 221 | P17405 | |
| ARSRCPDGSTCCELP | 211 | P28799 | |
| CAPSLRKCPICRSTI | 581 | Q13489 | |
| ACTRLCRPRSAPSRC | 186 | Q9NYJ7 | |
| MPTRVCCCCSALRPR | 1 | Q14156 | |
| GDKPCCRLSRRAQLC | 11 | P28907 | |
| RAAVCLCKEGRCPPV | 3776 | Q14517 | |
| CRPGVEGPRCDTCRS | 511 | Q16787 | |
| FPRCKPCSCGRRLCE | 1306 | Q16787 | |
| RRLCEEMTGQCRCPP | 1316 | Q16787 | |
| CDRDSGQCRCKPRIT | 1371 | Q16787 | |
| VAAERPCPTTCRCLG | 41 | Q6UXM1 | |
| LGCERREQCRPLPCV | 601 | Q5IJ48 | |
| NKPTRPGCEMCCRAR | 206 | Q9BYM8 | |
| SFPVALSCRCGPCRR | 101 | P01229 | |
| RTPTCEPATPLCCRR | 236 | P58166 | |
| RSCKGCQGPRPTDCL | 1571 | Q92824 | |
| VRICGKSEPECPACR | 626 | Q86XN8 | |
| SCLCGKFVLRPLRPC | 16 | Q16891 | |
| CGVPCLRTCRNPRGD | 1181 | P98088 | |
| CRKDPRVGRCLCKPN | 506 | O15230 | |
| RCPKCVAEECSKPRE | 336 | P29375 | |
| RCIPRSLCLSECPLE | 1106 | Q86WI3 | |
| PCRSVCERAKAGCAP | 106 | Q9H461 | |
| PEKLRQTPGCCRAEC | 426 | Q96SD1 | |
| CPCAGPACAERRRQT | 86 | Q9GZZ7 | |
| MSRRPCSCALRPPRC | 1 | Q9UKT4 | |
| RMLGGRPRCECAPDC | 111 | O95633 | |
| PRDRKPCRAGCFVCR | 341 | Q8TCT0 | |
| SCDCKRICRGGRPQA | 1331 | Q5JV73 | |
| NCEICECRPRPKKCR | 526 | Q9NZV1 | |
| RRPPRRGGCACCELL | 126 | Q8WW18 | |
| CLRDPCKGKGRCINR | 891 | Q14767 | |
| RCSCKPGVTGARCDR | 101 | Q13753 | |
| VCKPAVTGERCDRCR | 156 | Q13753 | |
| VRLTCCCCRFRIPEP | 221 | Q8N8Q3 | |
| PCERCELDTACPRGL | 931 | P35556 | |
| DRPRCCLRGKECSIN | 361 | Q9BX70 | |
| CTSRCPRPCRESAFK | 611 | P51172 | |
| PRTLALECPFCRRAC | 61 | Q6VVB1 | |
| TPGAPLCCTLCRERL | 496 | Q8IU81 | |
| GESPCPRCRKEARRL | 801 | Q9H0X9 | |
| LCPAGRRGPRCAETC | 976 | O75095 | |
| TCLCPPGRAGVRCER | 1276 | O75095 | |
| SEGCPRKRSCLREPC | 16 | Q93075 | |
| RKRSCLREPCDVAPS | 21 | Q93075 | |
| PCKPGVAGRRCDRCM | 421 | Q9HB63 | |
| CLRSRVRCMALKCPP | 221 | Q6ZWJ8 | |
| SPDCCALIRRCLAPK | 256 | Q9P1W9 | |
| CCCSSPGPRRESPRK | 56 | K7EJ46 | |
| SCCCLYKTCRRPRPV | 131 | Q8N114 | |
| MASSRCPAPRGCRCL | 1 | Q03518 | |
| EEEPRTCCGCRFPLL | 41 | Q14714 | |
| RCEGKLRPSCADSPC | 801 | Q99466 | |
| CVRPRCPGCSLDTCE | 191 | Q8IUL8 | |
| KTTCRCPLTQERPCD | 46 | A4QN01 | |
| SPEMCRTCRTGCPRG | 151 | Q9UBN6 | |
| TEEPRPCARCGKRFR | 221 | Q96EG3 | |
| KAPLCDCTCFGLPRR | 56 | Q9P2U8 | |
| ACRKEECKRVSPPSC | 2361 | P04275 | |
| MRPEPGGCCCRRTVR | 1 | O15270 | |
| KFCRPLLPSCTTRLC | 641 | Q9BQI7 | |
| SPPRRSLGCKRKREC | 261 | A6NKU9 | |
| PGEKRRRMACTCPNC | 496 | Q02086 | |
| CLAPCVRRLPFGKCR | 266 | Q8TCT7 | |
| RACCPICRRPIKDVI | 536 | A8MQ27 | |
| ARRDPTPVCCPSCRR | 241 | P26651 | |
| CGCSRTARPKDLPRD | 141 | Q9H1J7 | |
| ADCKRTTPGRRVCTC | 1486 | Q8WWQ8 | |
| TCGCSRAARPKDLPR | 161 | P41221 | |
| SCLCRARSCDSPRPR | 631 | Q9P283 | |
| LKKRGDPCSCQPRSR | 186 | O14836 | |
| QPVCRCRDRCEKEPS | 111 | Q96NZ8 | |
| CPLPRKVRRCFLCSR | 256 | Q8N3Z6 | |
| PERDVCRCPREGCGR | 241 | Q92664 | |
| QEGCRLCAPLRKCRP | 131 | P20333 | |
| SPLCPKRVCASLCRV | 56 | Q8N0V1 | |
| ASCDPRDLKSCNRPC | 26 | Q5T742 | |
| RPCLCLCSEEGRAPM | 36 | A6NLI5 | |
| LCSEEGRAPMRCPLC | 41 | A6NLI5 | |
| RPCLCLCSEEGRAPM | 36 | A6NGJ6 | |
| LCSEEGRAPMRCPSC | 41 | A6NGJ6 | |
| DEKPTCCRCRGRKRC | 471 | O75604 | |
| RPCLCLCSEEGRAPM | 36 | A6NI03 | |
| LCSEEGRAPMRCPSC | 41 | A6NI03 | |
| RPCRQRDCPSCKPFD | 96 | A0A1W2PP97 | |
| RPDKVPRDMRRCCFC | 5021 | O14686 | |
| CDPRSGRCPCKENVE | 441 | Q9Y6N6 | |
| PCSCRIPLLDCSRRK | 46 | O94898 | |
| APRPEKRCCKGFCID | 476 | O15399 |